Acasti Pharma Inc Announces Positive Results for Pharmacokinetic Bridging Study Call Transcript
Good day, ladies and gentlemen, and welcome to the Acasti Pharma Clinical and Business Update Conference Call. (Operator Instructions)
It is now my pleasure to turn the floor over to your host, Natalya Rudman, Investor Relations. Ma'am, the floor is yours.
Thank you, and good afternoon, everyone. I'd like to welcome you to Acasti Pharma's Clinical Update Conference Call. On the call with us this afternoon are Jan D'Alvise, President and CEO; Dr. Pierre Lemieux, Chief Operating Officer, Canada and Chief Scientific Officer; Dr. George Kottayil, Chief Operating Officer, U.S.; and Prashant Kohli, Vice President of Commercial Operations.
Following our prepared remarks, there will be a Q&A session. Should any questions remain after the call, please contact Crescendo Communications at (212) 671-1020. And I'd also like to remind everyone that statements on this conference call that are not statements of historical or current facts constitute forward
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |